전엑솜 시퀀스 시장 규모, 점유율 및 성장 분석 : 제품별, 기술별, 워크플로우별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Whole Exome Sequencing Market size was valued at USD 583.34 Million in 2024 and is poised to grow from USD 684.84 Million in 2025 to USD 2471.35 Million by 2033, growing at a CAGR of 17.4% during the forecast period (2026-2033).

The global market for whole exome sequencing is experiencing notable growth driven by advancements in technology, expanding applications in research and diagnostics, and decreasing costs. The rising demand for accurate and timely detection of genetic and chronic diseases has accelerated industry expansion, with healthcare professionals increasingly leveraging whole exome sequencing to uncover genetic variations linked to various conditions. This capability facilitates the development of personalized treatments tailored to individual genomic profiles. As such technologies become more accessible and cost-effective, healthcare facilities are adopting them at higher rates. The trend towards personalized medicine, where treatment is based on specific genetic markers, indicates a promising trajectory for the industry, with ongoing innovations likely to further enhance diagnostic capabilities and therapeutic strategies in healthcare.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Whole Exome Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Whole Exome Sequencing Market Segments Analysis

Global Whole Exome Sequencing Market is segmented by Product, Technology, Workflow, Application, End-use and region. Based on Product, the market is segmented into Instruments, Consumables, System, Kits and Services. Based on Technology, the market is segmented into Sequencing by Synthesis, ION Semiconductor Sequencing and Others. Based on Workflow, the market is segmented into Pre-Sequencing, Sequencing and Data Analysis. Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development, Personalized Medicines, Agriculture and Animal Research and Others. Based on End-use, the market is segmented into Academic And Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Whole Exome Sequencing Market

A significant factor contributing to the expansion of the global whole exome sequencing market is the rising demand for personalized medicine. By analyzing an individual's entire exome, healthcare providers can tailor treatment plans to align with each patient's unique genetic profile and vulnerability to diseases. This customized approach enhances the effectiveness of therapies, ultimately leading to better patient outcomes. Additionally, continuous advancements in sequencing technologies and data analysis are making whole exome sequencing increasingly accessible and cost-effective, thereby promoting its utilization in clinical environments. As the importance of individualized healthcare becomes more recognized, the demand for whole exome sequencing continues to grow, influencing the healthcare landscape.

Restraints in the Global Whole Exome Sequencing Market

The whole exome sequencing market encounters notable challenges due to the complexity and interpretation difficulties linked to the substantial volumes of genomic data produced. The analysis and interpretation of this extensive genetic information are often time-intensive and demand specialized knowledge. Furthermore, guaranteeing the accuracy and reliability of results is vital for informed medical decision-making. This necessitates the availability of advanced bioinformatics tools and expertise to effectively manage and interpret the data, which can hinder the widespread adoption of whole exome sequencing. Such constraints can ultimately limit its accessibility and practical application within various healthcare environments.

Market Trends of the Global Whole Exome Sequencing Market

The Global Whole Exome Sequencing market is experiencing a notable trend with the incorporation of artificial intelligence (AI) and machine learning (ML) technologies into data analysis and interpretation processes. These advanced analytical tools are increasingly utilized to manage the vast amounts of genomic data generated from whole exome sequencing, enabling the identification of crucial genetic patterns, variations, and disease correlations. By automating data processing and enhancing accuracy, AI and ML are changing the landscape of genomic analysis, leading to more rapid and precise detection of genetic variants. This integration not only supports improved diagnoses and personalized treatment options but also propels advancements in genomic medicine, positioning the whole exome sequencing market for significant growth.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Whole Exome Sequencing Market Size by Product & CAGR (2026-2033)

• Market Overview
• Instruments
• Consumables
• System
• Kits
• Services

Global Whole Exome Sequencing Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Sequencing by Synthesis
• ION Semiconductor Sequencing
• Others

Global Whole Exome Sequencing Market Size by Workflow & CAGR (2026-2033)

• Market Overview
• Pre-Sequencing
• Sequencing
• Data Analysis

Global Whole Exome Sequencing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Clinical Diagnostics
• Drug Discovery & Development
• Personalized Medicines
• Agriculture and Animal Research
• Others

Global Whole Exome Sequencing Market Size by End-use & CAGR (2026-2033)

• Market Overview
• Academic And Research Institutes
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Others

Global Whole Exome Sequencing Market Size & CAGR (2026-2033)

• North America (Product, Technology, Workflow, Application, End-use)
  • US
  • Canada
• Europe (Product, Technology, Workflow, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Workflow, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Workflow, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Workflow, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California, Inc. (PacBio) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies plc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Genomics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novogene Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Azenta, Inc. (formerly GENEWIZ) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CD Genomics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Psomagen, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bionano Genomics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dante Labs (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MGI Tech Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneDx Holdings Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Helix OpCo, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations